InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Pontus Forsell. Director active across 1 company, notably AlzeCure Pharma AB. Aggregated, 1 reports have been published. History available since 1 July 2026. The latest transaction was filed on 1 July 2026 (Purchase). Regulator: FIN-FSA. The full history is free.
1 of 1 declaration